Autoimmune and inflammatory diseases represent complex conditions wherein the body's immune system mistakenly targets its own tissues, resulting in inflammation and subsequent tissue damage. Typically, the immune system's role involves identifying and neutralizing foreign invaders, such as bacteria and viruses, while preserving the body's own cells. However, in autoimmune disorders, this intricate self-recognition mechanism malfunctions, leading to the immune system erroneously attacking healthy cells, tissues, and organs. This dysregulation manifests in over 80 recognized autoimmune diseases, each characterized by distinct symptoms and affecting various parts of the body. Conditions like rheumatoid arthritis, lupus, multiple sclerosis, type 1 diabetes, and inflammatory bowel diseases such as Crohn's disease and ulcerative colitis are prime examples. Conversely, inflammatory diseases stem from the body's response to injury, infection, or irritation. Inflammation itself is a vital process for healing, facilitating the removal of harmful stimuli and initiating tissue repair. However, chronic inflammation arises when the immune system remains continually activated, leading to ongoing tissue damage and contributing to ailments like asthma, chronic obstructive pulmonary disease (COPD), and cardiovascular diseases. Both autoimmune and inflammatory diseases exert profound impacts on an individual's quality of life, often necessitating long-term management strategies and treatments to control symptoms and avert complications. Treatment modalities typically encompass medications designed to suppress the immune response, mitigate inflammation, and manage symptoms. Additionally, lifestyle adjustments, including dietary modifications and regular exercise, often play integral roles in managing these conditions effectively.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States